USA

  • Accsys finalizes investment in $136mn Accoya production facility in USA

    AMSTERDAM: Accsys, the fast-growing and eco-friendly company that combines chemistry and technology to create sustainable wood building products, has concluded a final investment decision to construct and operate a new Accoya production facility in the USA, a statement noted. Final Investment Decision Accsys and Eastman Chemical Company have completed the remaining planning workstreams required…

  • Achilles Therapeutics prices its ADS at an IPO rate of $18

    LONDON: Syncona Ltd’s portfolio company Achilles Therapeutics plc has announced the pricing of its initial public offering (IPO) in the United States of 9.75 million American Depositary Shares (ADSs), at an initial public offering price of $18 per ADS for total gross proceeds of approximately $175.5 million. All ADSs sold in the IPO were…

  • Core One Labs to acquire Ketamine Infusions Centers of Texas, USA

    VANCOUVER: Core One Labs Inc. has entered into a definitive agreement to acquire Ketamine Infusion Centers of Texas Inc. (KICT), a US based health and wellness Ketamine Clinic. The Transaction is the first health and wellness operation for the Company in the United States. The acquisition of KICT allows the company to establish a…

  • Immedia Group establishes satellite presence in the USA

    LONDON: Immedia Group has established a satellite presence in the USA. The office, which is primarily focused on the Group’s AVC Immedia business is located in Houston Texas and will be headed up by Kacey White. Kacey has already worked with the Group on numerous projects over many years throughout the USA offering businesses…